Health Canada drug identification number

DIN 02520125 — HYPERHEP B 110 UNIT

HYPERHEP B is a solution of Hepatitis B Immunoglobulin marketed by GRIFOLS THERAPEUTICS LLC. The full Hepatitis B Immunoglobulin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02520125
Brand name
HYPERHEP B
Strength
110 UNIT
Dosage form
SOLUTION
Route
INTRAMUSCULAR
Manufacturer
GRIFOLS THERAPEUTICS LLC
Health Canada status
MARKETED
Drug class
Passive immunizing agent (hepatitis B hyperimmune globulin)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Hepatitis B Immunoglobulin products

DINBrandStrengthFormManufacturerStatus
02290979 HEPAGAM B 312 UNIT SOLUTION KI BIOPHARMA LLC MARKETED
02520001 HYPERHEP B 220 UNIT SOLUTION GRIFOLS THERAPEUTICS LLC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.